Similarly, on another interesting angle, other researchers have tried to target the glycogen synthase kinase-3 beta (GSK-3β) pathway (within ferroptosis) via which tau aggregation is thought to occur in tauopathy [148]. The gene discussed is MAPT; the disease is tauopathy.